Financial Announcements Archives | Page 2 of 23 | Be Korea-savvy

Archive by category Financial Announcements

RedHill Biopharma Reports 2017 Third Quarter Financial Results

RedHill Biopharma Reports 2017 Third Quarter Financial Results

TEL-AVIV, Israel and RALEIGH, N.C., Nov. 13 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary drugs for gastrointestinal and inflammatory diseases and cancer, today reported its financial results for the quarter ended September 30, 2017. [...]

Neuralstem Reports Third Quarter 2017 Fiscal Results and Provides Clinical and Business Update

Neuralstem Reports Third Quarter 2017 Fiscal Results and Provides Clinical and Business Update

GERMANTOWN, Md., Nov. 13 (Korea Bizwire) — Neuralstem, Inc. (NASDAQ:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell technology, reported its financial results for the three and nine month periods ended September 30, 2017.             “We continue to evaluate the full Phase 2 data set for NSI-189 [...]

Telix Pharmaceuticals Limited Successfully Completes $50 Million Oversubscribed Initial Public Offering

Telix Pharmaceuticals Limited Successfully Completes $50 Million Oversubscribed Initial Public Offering

MELBOURNE, Australia, Nov. 9 (Korea Bizwire) — Telix Pharmaceuticals Limited (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of diagnostic and therapeutic products based on targeted radiopharmaceuticals or “molecularly-targeted radiation” (MTR), has successfully raised $50 million following the close of its fully underwritten Initial Public Offering (IPO). The IPO was strongly supported [...]

RedHill Biopharma Prices Public Offering of its American Depositary Shares

RedHill Biopharma Prices Public Offering of its American Depositary Shares

TEL-AVIV, Israel and RALEIGH, N.C., Nov. 8 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary drugs for gastrointestinal and inflammatory diseases and cancer, today announced the pricing of its previously announced underwritten public offering for [...]

RedHill Biopharma Announces Proposed Public Offering of its American Depositary Shares

RedHill Biopharma Announces Proposed Public Offering of its American Depositary Shares

TEL-AVIV, Israel and RALEIGH, N.C., Nov. 7 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary drugs for gastrointestinal and inflammatory diseases and cancer, today announced that it intends to offer its American Depositary Shares (“ADSs”), [...]

Constellation Brands Prices Offering of Senior Notes

Constellation Brands Prices Offering of Senior Notes

VICTOR, N.Y., Oct. 31 (Korea Bizwire) — Constellation Brands, Inc. (NYSE:STZ)(NYSE:STZ.B), a leading beverage alcohol company, announced today that it priced the public offering of $2.0 billion aggregate principal amount of Senior Notes, consisting of (i)  $600.0 million of 2.000% Senior Notes due 2019 (the “2019 notes”) for a public offering price of 99.860% of the [...]

Abiomed Announces Q2 FY 2018 Revenue of $132.8 Million, Up 29% and Record U.S. Patient Utilization, Up 33%

Abiomed Announces Q2 FY 2018 Revenue of $132.8 Million, Up 29% and Record U.S. Patient Utilization, Up 33%

DANVERS, Mass., Oct. 26 (Korea Bizwire) — Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today reported second quarter fiscal 2018 revenue of $132.8 million, an increase of 29% compared to revenue of $103.0 million for the same period of fiscal 2017. Second quarter fiscal 2018 GAAP net income was $24.5 million [...]

Nasdaq Reports Third Quarter 2017 Results; Delivers Strong Profitability and Income Growth

Nasdaq Reports Third Quarter 2017 Results; Delivers Strong Profitability and Income Growth

NEW YORK, Oct. 25 (Korea Bizwire) — Nasdaq, Inc. (Nasdaq:NDAQ) today reported financial results for the third quarter of 2017.  Third quarter 2017 net revenues were $607 million, up $22 million or 4% from $585 million in the prior year period.  The third quarter increase in net revenues included a $15 million, or 3%, increase [...]

Integra LifeSciences Announces Definitive Agreement to Sell Certain Neurosurgery Assets to Natus Medical Incorporated

Integra LifeSciences Announces Definitive Agreement to Sell Certain Neurosurgery Assets to Natus Medical Incorporated

PLAINSBORO, N.J., Sept. 11 (Korea Bizwire) —  Integra LifeSciences Holdings Corporation (Nasdaq:IART), a global leader in medical technology, today announced that it has signed a definitive agreement to sell certain neurosurgery assets to Natus Medical for $47.5 million. The divestiture is contingent on the consummation of Integra’s proposed acquisition of Codman Neurosurgery from Johnson & [...]